Hurricane Legislation Tables Drug Safety Issues
This article was originally published in The Pink Sheet Daily
Executive Summary
Congress will likely postpone consideration of drug safety issues to address emergency legislation relating to Hurricane Katrina, Senate Budget Committee Senior FDA Health Counsel Peggy Binzer said at the Food & Drug Law Institute conference on promotion and advertising Sept. 19
You may also be interested in...
Sen. Gregg To Propose Clinical Trial Database Act
Act would mandate registry of clinical trials performed for all U.S. marketed products only; competing bill calls for database of all drugs, biologics and devices.
DTC Ads Being Pushed As Drug Safety Problem By Sen. Kennedy
Massachusetts Democrat's statements at a Health Committee hearing suggest he will push for drug safety legislation to limit direct-to-consumer advertising for newly approved drugs. He also urges legislation granting FDA authority to require drug labeling changes and post-marketing safety studies.
Tarceva Pancreatic Cancer Indication Turned Down In The EU
Roche will consider requesting a re-examination of the negative decision by the Committee for Medicinal Products for Human Use.